Patents by Inventor Thomas J. Wickham
Thomas J. Wickham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6998263Abstract: The present invention provides a library of viral vectors, wherein each member comprises a first heterologous DNA encoding a first gene product and a second heterologous DNA encoding a second gene product. The first heterologous DNA is common to each member of the library, while the second heterologous DNA varies between members of the library. The present invention additionally provides a method of constructing a library of viral vectors. The method comprises carrying out homologous recombination between a first DNA molecule and a second DNA molecule to form a pool of intermediate viral vector genomes. One or more linear third DNA molecules are ligated into the pool of intermediate viral genomes to produce a library of viral vector genomes. Alternatively, homologous recombination between linear DNA molecules and recipient DNA molecules produces a library of viral vector genomes. The library of viral vector genomes is converted into a library of viral vectors.Type: GrantFiled: February 9, 2001Date of Patent: February 14, 2006Assignee: GenVec, Inc.Inventors: Imre Kovesdi, Duncan L. McVey, Thomas J. Wickham, Joseph T. Bruder, Douglas E. Brough
-
Patent number: 6951755Abstract: The present invention provides a recombinant adenovirus comprising coat proteins that lack native binding. In particular, the present invention provides a recombinant adenovirus comprising a penton base protein and a fiber protein, wherein the penton base protein and the fiber protein lack native binding. The present invention further provides a recombinant adenovirus comprising (a) a penton base protein that lacks native binding and (b) a nonnative amino acid sequence that binds a cell-surface binding site.Type: GrantFiled: October 24, 2001Date of Patent: October 4, 2005Assignee: GenVec, Inc.Inventors: Thomas J. Wickham, Imre Kovesdi, Douglas E. Brough
-
Publication number: 20040167088Abstract: The invention provides a method of expressing an exogenous nucleic acid in a mammal. The method comprises slowly releasing into the bloodstream a dose of replication-deficient or conditionally-replicating adenoviral vector having reduced ability to transduce mesothelial cells and hepatocytes. The normalized average bloodstream concentration of the adenovirus over 24 hours post-administration is at least about 1%. Alternatively, the normalized average bloodstream concentration over 24 hours post-administration is at least about 5-fold greater than the normalized average bloodstream concentration for an equivalent dose of a wild-type adenoviral vector. A method of destroying tumor cells in a mammal also is provided.Type: ApplicationFiled: February 25, 2003Publication date: August 26, 2004Applicant: GenVec, Inc.Inventors: Thomas J. Wickham, Masaki Akiyama
-
Patent number: 6756044Abstract: The present invention provides a complex that includes a virion having a ligand that recognizes an epitope present on an immune effector cell surface and at least a first nucleic acid encoding a first non-native antigen. The invention also provides a library including a plurality of such complexes, in which antigens of at least two of the plurality are different. Using such reagents, the invention provides a method of precipitating an immune response within an immune effector cell, wherein such a complex is delivered to the cell under conditions sufficient for the cell to mount an immune response to the antigen. When applied in vivo, the method can serve to immunize an animal from the pathogen. Moreover, using a library including a plurality of complexes, which contains at least one test antigen, the invention provides a method of assessing the antigenicity of the test antigen.Type: GrantFiled: July 17, 2000Date of Patent: June 29, 2004Assignee: GenVec, Inc.Inventors: Petrus W. Roelvink, Joseph T. Bruder, Imre Kovesdi, Thomas J. Wickham
-
Patent number: 6740525Abstract: The present invention provides a chimeric protein IX (pIX). The chimeric pIX protein has an adenoviral pIX domain and also a non-native amino acid. Where the non-native amino acid is a ligand that binds to a substrate present on the surface cells, the chimeric pIX can be used to target vectors containing such proteins to desired cell types. Thus, the invention provides vector systems including such chimeric pIX proteins as well as methods of infecting cells using such vector systems.Type: GrantFiled: February 9, 2001Date of Patent: May 25, 2004Assignee: GenVec, Inc.Inventors: Petrus W. Roelvink, Imre Kovesdi, Thomas J. Wickham
-
Patent number: 6649407Abstract: The present invention provides a chimeric adenovirus fiber protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence in a conformationally-restrained manner. Such a chimeric adenovirus fiber protein according to the invention is able to direct entry into cells of a vector comprising the chimeric fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than the chimeric adenovirus fiber protein. The nonnative amino acid sequences encodes a peptide motif that comprises an epitope for an antibody, or a ligand for a cell surface receptor, that can be employed in cell targeting. The present invention also pertains to vectors comprising such a chimeric adenovirus fiber protein, and to methods of using such vectors.Type: GrantFiled: October 1, 2001Date of Patent: November 18, 2003Assignee: GenVec, Inc.Inventors: Thomas J. Wickham, Petrus W. Roelvink, Imre Kovesdi
-
Publication number: 20030166286Abstract: A recombinant adenovirus comprising a chimeric adenoviral fiber protein comprising a non-adenoviral amino acid sequence in place of or in addition to a native fiber amino acid sequence, wherein the chimeric adenoviral fiber protein comprises a trimerization domain and the non-adenoviral amino acid sequence is of a size such that folding of the chimeric adenoviral fiber protein and assembly of a complex comprising the chimeric adenoviral fiber protein and a penton base is not impeded, and an adenoviral transfer vector for the generation of such a recombinant adenovirus are provided.Type: ApplicationFiled: June 17, 2002Publication date: September 4, 2003Applicant: Cornell Research Foundation, Inc.Inventors: Thomas J. Wickham, Erik Falck-Pedersen, Petrus W. Roelvink, Joseph T. Bruder, Jason Gall, Imre Kovesdi
-
Patent number: 6576456Abstract: The invention provides a chimeric adenovirus fiber protein including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell.Type: GrantFiled: June 4, 1999Date of Patent: June 10, 2003Assignees: Cornell Research Foundation, Inc., GenVec, Inc.Inventors: Thomas J. Wickham, Erik Falck-Pedersen, Petrus W. Roelvink, Joseph T. Bruder, Jason Gall, Imre Kovesdi
-
Publication number: 20030099619Abstract: The invention provides adenoviral coat proteins comprising various non-native ligands. Further, the present invention provides an adenoviral vector that elicits less reticulo-endothelial system (RES) clearance in a host animal than a corresponding wild-type adenovirus. Also provided by the invention is a system comprising a cell having a non-native cell-surface receptor and a virus having a non-native ligand, wherein the non-native ligand of the virus binds the non-native cell-surface receptor of the cell. Using this system, a virus can be propagated. Further provided by the invention is a method of controlled gene expression utilizing selectively replication competence, a method of assaying for gene function, a method of isolating a nucleic acid, and a method of identifying functionally related coding sequences. Additionally, the invention provides a cell-surface receptor, which facilitates internalization.Type: ApplicationFiled: November 25, 2002Publication date: May 29, 2003Applicant: GenVec, Inc.Inventors: Thomas J. Wickham, Imre Kovesdi, Petrus W. Roelvink, David Einfeld, Douglas E. Brough, Alena Lizonova
-
Publication number: 20030022355Abstract: The present invention provides a recombinant adenovirus comprising coat proteins that lack native binding. In particular, the present invention provides a recombinant adenovirus comprising a penton base protein and a fiber protein, wherein the penton base protein and the fiber protein lack native binding. The present invention further provides a recombinant adenovirus comprising (a) a penton base protein that lacks native binding and (b) a nonnative amino acid sequence that binds a cell-surface binding site.Type: ApplicationFiled: October 24, 2001Publication date: January 30, 2003Applicant: GenVec, Inc.Inventors: Thomas J. Wickham, Imre Kovesdi, Douglas E. Brough
-
Publication number: 20020151027Abstract: The present invention provides a chimeric adenovirus fiber protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence in a conformationally-restrained manner. Such a chimeric adenovirus fiber protein according to the invention is able to direct entry into cells of a vector comprising the chimeric fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than the chimeric adenovirus fiber protein. The nonnative amino acid sequences encodes a peptide motif that comprises an epitope for an antibody, or a ligand for a cell surface receptor, that can be employed in cell targeting. The present invention also pertains to vectors comprising such a chimeric adenovirus fiber protein, and to methods of using such vectors.Type: ApplicationFiled: October 1, 2001Publication date: October 17, 2002Applicant: GenVec, Inc.Inventors: Thomas J. Wickham, Petrus W. Roelvink, Imre Kovesdi
-
Patent number: 6465253Abstract: The present invention provides a chimeric adenovirus coat protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence. Such a chimeric adenovirus coat protein according to the invention is able to direct entry into cells of a vector comprising the coat protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus coat protein rather than the chimeric adenovirus coat protein. The chimeric coat protein preferably is a fiber, hexon, or penton protein. The present invention also provides an adenoviral vector that comprises the chimeric adenovirus coat protein, as well as methods of constructing and using such a vector.Type: GrantFiled: January 29, 1999Date of Patent: October 15, 2002Assignee: GenVec, Inc.Inventors: Thomas J. Wickham, Imre Kovesdi, Douglas E. Brough
-
Patent number: 6455314Abstract: The present invention provides a recombinant protein having an amino terminus of an adenoviral fiber protein and having a trimerization domain. A fiber incorporating such a protein exhibits reduced affinity for a native substrate than does a wild-type adenoviral fiber trimer. The present invention further provides an adenovirus incorporating the recombinant protein of the present invention.Type: GrantFiled: September 10, 1999Date of Patent: September 24, 2002Assignee: GenVec, Inc.Inventors: Thomas J. Wickham, Imre Kovesdi, Petrus W. Roelvink, Joseph T. Bruder
-
Publication number: 20020099024Abstract: The invention provides a chimeric adenovirus fiber protein including a nonnative amino acid sequence, and a chimeric adenovirus fiber protein lacking a native amino acid receptor-binding sequence. The chimeric protein trimerizes when produced in a mammalian cell.Type: ApplicationFiled: June 4, 1999Publication date: July 25, 2002Inventors: THOMAS J. WICKHAM, ERIK FALCK-PEDERSEN, PETRUS W. ROELVINK, JOSEPH T. BRUDER, JASON GALL, IMRE KOVESDI
-
Patent number: 6329190Abstract: The present invention provides a chimeric adenovirus fiber protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence in a conformationally-restrained manner. Such a chimeric adenovirus fiber protein according to the invention is able to direct entry into cells of a vector comprising the chimeric fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than the chimeric adenovirus fiber protein. The nonnative amino acid sequences encodes a peptide motif that comprises an epitope for an antibody, or a ligand for a cell surface receptor, that can be employed in cell targeting. The present invention also pertains to vectors comprising such a chimeric adenovirus fiber protein, and to methods of using such vectors.Type: GrantFiled: December 6, 1999Date of Patent: December 11, 2001Assignee: GenVec, Inc.Inventors: Thomas J. Wickham, Petrus W. Roelvink, Imre Kovesdi
-
Publication number: 20010047081Abstract: The present invention provides a chimeric protein IX (pIX). The chimeric pIX protein has an adenoviral pIX domain and also a non-native amino acid. Where the non-native amino acid is a ligand that binds to a substrate present on the surface cells, the chimeric pIX can be used to target vectors containing such proteins to desired cell types. Thus, the invention provides vector systems including such chimeric pIX proteins as well as methods of infecting cells using such vector systems.Type: ApplicationFiled: February 9, 2001Publication date: November 29, 2001Applicant: GenVec, Inc.Inventors: Petrus W. Roelvink, Imre Kovesdi, Thomas J. Wickham
-
Publication number: 20010026794Abstract: The present invention provides a library of viral vectors, wherein each member comprises a first heterologous DNA encoding a first gene product and a second heterologous DNA encoding a second gene product. The first heterologous DNA is common to each member of the library, while the second heterologous DNA varies between members of the library. The present invention additionally provides a method of constructing a library of viral vectors. The method comprises carrying out homologous recombination between a first DNA molecule and a second DNA molecule to form a pool of intermediate viral vector genomes. One or more linear third DNA molecules are ligated into the pool of intermediate viral genomes to produce a library of viral vector genomes. Alternatively, homologous recombination between linear DNA molecules and recipient DNA molecules produces a library of viral vector genomes. The library of viral vector genomes is converted into a library of viral vectors.Type: ApplicationFiled: February 9, 2001Publication date: October 4, 2001Applicant: GenVec, Inc.Inventors: Imre Kovesdi, Duncan L. McVey, Thomas J. Wickham, Joseph T. Bruder, Douglas E. Brough
-
Patent number: 6153435Abstract: The present invention provides a chimeric adenoviral coat protein (particularly a chimeric adenovirus hexon and/or fiber protein). The chimeric adenovirus coat protein has a decreased ability or inability to be recognized by a neutralizing antibody directed against the corresponding wild-type adenovirus coat protein. The invention also provides an adenovirus comprising a chimeric adenovirus coat protein, and methods of constructing and using such an adenovirus, for instance, in gene therapy.Type: GrantFiled: June 17, 1999Date of Patent: November 28, 2000Assignees: Cornell Research Foundation, Inc., GenVec, Inc.Inventors: Ronald G. Crystal, Erik Falck-Pedersen, Jason Gall, Imre Kovesdi, Thomas J. Wickham
-
Patent number: 6127525Abstract: The present invention provides a chimeric adenoviral coat protein (particularly a chimeric adenovirus hexon and/or fiber protein). The chimeric adenovirus coat protein has a decreased ability or inability to be recognized by a neutralizing antibody directed against the corresponding wild-type adenovirus coat protein. The invention also provides an adenovirus comprising a chimeric adenovirus coat protein, and methods of constructing and using such an adenovirus, for instance, in gene therapy.Type: GrantFiled: March 13, 1997Date of Patent: October 3, 2000Assignees: Cornell Research Foundation, Inc., GenVec, Inc.Inventors: Ronald G. Crystal, Erik Falck-Pedersen, Jason Gall, Imre Kovesdi, Thomas J. Wickham
-
Patent number: 6057155Abstract: The present invention provides a chimeric adenovirus fiber protein, which differs from the wild-type coat protein by the introduction of a nonnative amino acid sequence in a conformationally-restrained manner. Such a chimeric adenovirus fiber protein according to the invention is able to direct entry into cells of a vector comprising the chimeric fiber protein that is more efficient than entry into cells of a vector that is identical except for comprising a wild-type adenovirus fiber protein rather than the chimeric adenovirus fiber protein. The nonnative amino acid sequences encodes a peptide motif that comprises an epitope for an antibody, or a ligand for a cell surface receptor, that can be employed in cell targeting. The present invention also pertains to vectors comprising such a chimeric adenovirus fiber protein, and to methods of using such vectors.Type: GrantFiled: August 6, 1998Date of Patent: May 2, 2000Assignee: GenVec, Inc.Inventors: Thomas J. Wickham, Petrus W. Roelvink, Imre Kovesdi